Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, is proud to announce that AAT and our lead product Algeness® were selected as one of the top two finalists in the recent Terra2 Solutions Skin Health Innovation Competition, finishing as the top aesthetic innovation and second overall in this prestigious, global event.
As part of their commitment to investing in and supporting the growth of innovative skin health competitions, Gore Range Capital partnered with Terra2 Solutions, a global think tank, and DermX Media Group, a leader in dermatology education, to host the Terra2 Solutions Skin Health Innovation Competition. The finals of the competition were held during the recent 18th Annual Winter Clinical Dermatology Conference-Hawaii® (WC21) that was held virtually this year and attracted 3,700 attendees.
Doug Abel, CEO of AAT, commented, "We were very honored that Algeness® was invited to participate in this prestigious competition, pleased to be initially selected as one of the top four semifinalists to present during WC21, and delighted to finish as one of the top two as selected by a group of industry leaders and highly respected physicians. This notable recognition from potential customers and investors underscores the unique advantages of the Algeness® technology as a differentiator in the global dermal filler market."
Participating companies were invited to present to a panel of expert judges and providers in the fields of clinical dermatology, aesthetic medicine, and other aspects of skin health, and executive leaders of pharmaceutical, medical device, diagnostic, and IT companies. Four semifinalists including AAT presented their pitch videos to the entire audience during the meeting, and the two finalists, AAT and Mindera Corporation were given the opportunity to present a live pitch to be followed by questions from the panel of judges.
"The dermal filler market is one of the most attractive segments in healthcare. Advanced Aesthetic Technologies has the know-how, the assets, and the capabilities necessary to bring innovative and differentiated products to this market. The recent Terra2 Solutions Skin Health Competition recognized AAT's Algeness® as a finalist among the most innovative technologies in medical skin health in the world," said Humberto Antunes, Founder of Terra2 Solutions, a Partner at Gore Range, and former global CEO of Galderma Laboratories.
According to board certified dermatologist Valerie Callender, MD, FAAD, of Callender Dermatology and Cosmetic Center in Glenn Dale, MD, who served as one of the judges for the Terra2 Solutions competition, "The unique attributes of Algeness® as presented will provide an important addition to the dermal filler market, filling a need for a product that offers a differentiated capability for achieving facial shape and contour definition and the potential for an outstanding safety profile."